Brain Fat, Mood Meds, and Keto Performance: Lab Notes May 05

Deep within your DNA lies a genetic switch—rs174583—that may shape how your brain’s communication network develops over a lifetime. This SNP tags a human-specific haplotype in the FADS2 gene, which governs the body’s ability to produce long-chain polyunsaturated fatty acids (LC-PUFAs), essential building blocks for brain cell insulation. A new study reveals that people with two copies of the minor T allele show atypical white matter development, failing to display the normal spike in fractional anisotropy (FA)—a measure of neural pathway integrity—during early adulthood.

Using advanced neuroimaging across ages 9 to 86, researchers found that CC/CT carriers follow a predictable brain maturation curve: FA rises into early adulthood, then gradually declines. TT homozygotes, however, show a flattened trajectory. This divergence was significant in critical tracts like the corpus callosum and superior longitudinal fasciculus—areas vital for cognition and connectivity.

The implication? Your genes may dictate how well your brain wires itself based on fat metabolism. While LC-PUFAs are abundant in animal fats, not everyone can make them efficiently. This genetic variation could help explain differences in cognitive resilience, neurodevelopmental outcomes, and even vulnerability to brain aging.

Key dietary takeaway: If you’re a poor converter of plant-based fats to brain-critical LC-PUFAs, direct sources like fatty fish may be especially important.

Best known for weight loss and diabetes control, GLP-1 receptor agonists like semaglutide and liraglutide may have a surprising side effect: improved mood. A new meta-analysis of clinical trials reveals these drugs exert measurable antidepressant effects, independent of their metabolic benefits. The analysis, which included data from randomized controlled trials, found consistent reductions in depression scores among patients using GLP-1RAs compared to placebo.

The mechanism? GLP-1 receptors are densely expressed in brain regions tied to emotional regulation, including the hippocampus and prefrontal cortex. Animal studies suggest these drugs reduce neuroinflammation, enhance neuroplasticity, and modulate stress responses—pathways long implicated in depression. While the exact neural circuitry is still being mapped, the evidence for mood modulation is now too strong to ignore.

This doesn’t mean GLP-1 drugs are ready for prime time as antidepressants—but they may offer dual benefits for patients with metabolic syndrome and depression. Future trials are already underway to test their efficacy in major depressive disorder.

For now, clinicians should be aware: when prescribing for diabetes or obesity, mood improvements may be more than just a side effect of weight loss.

Endurance athletes on ketogenic diets have long hoped for a loophole: if you can’t use carbs for fuel, maybe just tasting them could trick the brain into better performance. That’s the theory behind carbohydrate mouth rinsing—a tactic shown to enhance output in carb-adapted athletes by stimulating oral receptors linked to motor drive. But a new study delivers bad news for keto cyclists: after five days on a ketogenic diet, carb rinsing does not improve 40km time-trial performance.

The trial tested trained cyclists under two conditions: habitual diet vs. 5-day keto. Despite successful ketosis, mouth rinsing with a carbohydrate solution failed to rescue performance, with no significant difference in completion time, power output, or perceived effort. This suggests that the brain’s motivational response to oral carbs depends on systemic carbohydrate availability—or that five days isn’t enough to fully adapt, leaving the central nervous system ‘expecting’ fuel it can’t use.

The takeaway? Metabolic context matters. The brain doesn’t respond to sensory tricks when the body is in a prolonged fat-burning state. For keto athletes, performance may hinge more on full metabolic adaptation than on psychological hacks.

The carnivore diet—eating only animal products—has gained a cult following for its promises of weight loss, mental clarity, and autoimmune relief. But a new investigative video raises alarms: why are some strict carnivores developing insulin resistance and type 2 diabetes? With a Pro score of 21.0 to 14.0, the video presents case studies, blood work, and expert interviews suggesting that zero-carb eating may backfire metabolically in certain individuals.

Possible culprits include protein-induced gluconeogenesis, saturated fat overload, gut microbiome depletion, and loss of metabolic flexibility. Without dietary carbohydrates, the body may become less efficient at processing glucose when it’s eventually consumed—potentially increasing diabetes risk over time. Some experts suggest that while short-term benefits are real, long-term metabolic consequences remain poorly understood.

The video doesn’t condemn carnivory outright but urges caution, monitoring, and individualization. As with any extreme diet, what works for one body may harm another.